The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors

被引：8
|
作者：
Yang, Allen S. [1 ]
Yang, Brandon J. [2 ]
机构：
[1] Spectrum Pharmaceut, Irvine, CA 92618 USA
[2] Albert Einstein Acad, Santa Clarita, CA 91355 USA
来源：
EPIGENOMICS | 2016年 / 8卷 / 01期
关键词：
cancer; DNA methylation inhibitors; epigenetic therapy; histone deacetylase inhibitors; ACUTE MYELOID-LEUKEMIA; LOW-DOSE DECITABINE; MYELODYSPLASTIC SYNDROMES; HYPOMETHYLATING AGENTS; DNMT3A MUTATIONS; VALPROIC ACID; AZACITIDINE; TRIAL;
D O I：
10.2217/epi.15.94
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：9 / 12
页数：4
相关论文
共 13 条
  • [1] What is Drosophila telling us about cancer?
    De Lorenzo, C
    Mechler, BM
    Bryant, PJ
    CANCER AND METASTASIS REVIEWS, 1999, 18 (02) : 295 - 311
  • [2] What is Drosophila Telling Us About Cancer?
    Cécilia De Lorenzo
    Bernard M. Mechler
    Peter J. Bryant
    Cancer and Metastasis Reviews, 1999, 18 : 295 - 311
  • [3] Inhibitors of DNA Methylation, Histone Deacetylation, and Histone Demethylation: A Perfect Combination for Cancer Therapy
    Zahnow, C. A.
    Topper, M.
    Stone, M.
    Murray-Stewart, T.
    Li, H.
    Baylin, S. B.
    Casero, R. A., Jr.
    ADVANCES IN CANCER RESEARCH, VOL 130, 2016, 130 : 55 - 111
  • [4] Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries
    Wongtrakoongate, Patompon
    WORLD JOURNAL OF STEM CELLS, 2015, 7 (01): : 137 - 148
  • [5] DNA Methyltransferase Inhibitors and Their Emerging Role in Epigenetic Therapy of Cancer
    Gnyszka, Agnieszka
    Jastrzebski, Zenon
    Flis, Sylwia
    ANTICANCER RESEARCH, 2013, 33 (08) : 2989 - 2996
  • [6] Emerging DNA methylation inhibitors for cancer therapy: challenges and prospects
    Gonzalez-Fierro, Aurora
    Duenas-Gonzalez, Alfonso
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2019, 4 (01): : 27 - 35
  • [7] Epigenetic therapy of acute myeloid leukemia using 5-aza-2′-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
    Momparler, Richard L.
    Cote, Sylvie
    Momparler, Louise F.
    Idaghdour, Youssef
    CLINICAL EPIGENETICS, 2014, 6
  • [8] DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy
    Worm, J
    Guldberg, P
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2002, 31 (08) : 443 - 449
  • [9] DNA Methyltransferase-1 Inhibitors as Epigenetic Therapy for Cancer
    Singh, Varinder
    Sharma, Prince
    Capalash, Neena
    CURRENT CANCER DRUG TARGETS, 2013, 13 (04) : 379 - 399
  • [10] Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery
    Ganesan, A.
    Nolan, L.
    Crabb, S. J.
    Packham, G.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 963 - 981
12